Phosphodiesterase 4 Inhibitor [EPC]

Phosphodiesterase 4 Inhibitor [EPC] was reported 163127 times

Drugs of the Phosphodiesterase 4 Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 437 0.6542
1 HEPATIC ENZYME 82 0.5503
2 C-REACTIVE PROTEIN 509 0.5491
3 LUPUS VULGARIS 643 0.5103
4 DEEP VEIN THROMBOSIS POSTOPERATIVE 1005 0.5017
5 RHEUMATIC FEVER 2214 0.4962
6 SWOLLEN JOINT COUNT INCREASED 1574 0.4931
7 GRIP STRENGTH 112 0.4891
8 SWOLLEN JOINT COUNT 121 0.4840
9 RED BLOOD CELL SEDIMENTATION RATE 130 0.4659
10 FACET JOINT SYNDROME 1446 0.4437
11 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 811 0.3910
12 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 213 0.3797
13 RETINITIS 643 0.3719
14 DISLOCATION OF VERTEBRA 819 0.3587
15 X-RAY ABNORMAL 613 0.3425
16 HYPOCHOLESTEROLAEMIA 113 0.3201
17 RHEUMATOID FACTOR POSITIVE 1793 0.3101
18 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2160 0.3012
19 DUODENAL ULCER PERFORATION 2235 0.3002
20 SERONEGATIVE ARTHRITIS 309 0.2696
21 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 28 0.2667
22 PERIPHERAL VENOUS DISEASE 1062 0.2598
23 C-REACTIVE PROTEIN ABNORMAL 1611 0.2509
24 BONE EROSION 876 0.2475
25 ENTHESOPATHY 360 0.2300
26 HELICOBACTER INFECTION 2196 0.2135
27 FOLLICULITIS 2159 0.2057
28 PSORIATIC ARTHROPATHY 8345 0.2054
29 MUSCLE INJURY 1654 0.1994
30 HAND DEFORMITY 2511 0.1913
31 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1197 0.1841
32 PEMPHIGUS 2284 0.1825
33 BREAST CANCER STAGE III 1131 0.1745
34 GRANULOMA SKIN 143 0.1742
35 SYNOVITIS 3071 0.1701
36 ONYCHOMADESIS 697 0.1659
37 OVERLAP SYNDROME 116 0.1657
38 PSORIASIS 20775 0.1589
39 REBOUND PSORIASIS 90 0.1549
40 GRIP STRENGTH DECREASED 1326 0.1505
41 HYPERCHOLESTEROLAEMIA 1440 0.1490
42 LIP DRY 1345 0.1479
43 PORPHYRIA ACUTE 204 0.1422
44 PERICARDITIS 2325 0.1382
45 BLEPHAROSPASM 850 0.1349
46 WOUND INFECTION 1455 0.1327
47 JOINT RANGE OF MOTION DECREASED 1729 0.1288
48 BURSITIS 1500 0.1235
49 TENOSYNOVITIS 336 0.1217
50 GLOSSODYNIA 2580 0.1151
51 BLOOD PARATHYROID HORMONE DECREASED 168 0.1133
52 ONYCHOMYCOSIS 495 0.1127
53 PALMOPLANTAR PUSTULOSIS 59 0.1115
54 DRUG TOLERANCE DECREASED 312 0.1110
55 AUTOIMMUNE DISORDER 1046 0.1072
56 LIVE BIRTH 889 0.1062
57 BODY TINEA 59 0.1054
58 IRRITABLE BOWEL SYNDROME 2154 0.1004
59 DEATH NEONATAL 137 0.0984
60 FIBROMYALGIA 2335 0.0960
61 WOUND 2634 0.0941
62 EXOSTOSIS 856 0.0936
63 PUSTULAR PSORIASIS 308 0.0896
64 THERAPY NON-RESPONDER 3955 0.0879
65 NAIL DISORDER 768 0.0877
66 ALANINE AMINOTRANSFERASE ABNORMAL 185 0.0876
67 DACTYLITIS 85 0.0866
68 TENSION HEADACHE 368 0.0855
69 INFUSION SITE REACTION 253 0.0846
70 SCIATICA 1343 0.0842
71 RED BLOOD CELL SEDIMENTATION RATE INCREASED 908 0.0820
72 FINGER DEFORMITY 372 0.0767
73 SYSTEMIC LUPUS ERYTHEMATOSUS 2688 0.0757
74 TYPE 2 DIABETES MELLITUS 2545 0.0755
75 LIVER INJURY 1800 0.0733
76 JOINT DISLOCATION 768 0.0726
77 PRODUCT DOSE OMISSION 4644 0.0711
78 PANNICULITIS 171 0.0706
79 LUPUS-LIKE SYNDROME 631 0.0695
80 OBESITY 1067 0.0669
81 WALKING AID USER 436 0.0661
82 APPLICATION SITE PAIN 1441 0.0654
83 FOOT DEFORMITY 714 0.0644
84 JOINT ANKYLOSIS 36 0.0634
85 IMPAIRED HEALING 2073 0.0631
86 BACK INJURY 685 0.0629
87 RHEUMATOID NODULE 171 0.0620
88 CONTRAINDICATED PRODUCT ADMINISTERED 1862 0.0614
89 THERAPEUTIC PRODUCT EFFECT DECREASED 2742 0.0612
90 PRODUCT LABEL CONFUSION 347 0.0595
91 LOWER LIMB FRACTURE 1122 0.0583
92 SPONDYLITIS 208 0.0571
93 BREAST CANCER STAGE II 462 0.0555
94 ARTHROPATHY 3080 0.0554
95 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 27 0.0516
96 ABDOMINAL DISCOMFORT 8477 0.0505
97 HIP ARTHROPLASTY 773 0.0504
98 BLOOD CHOLESTEROL INCREASED 2343 0.0502
99 RHEUMATOID LUNG 47 0.0492
100 C-REACTIVE PROTEIN INCREASED 1786 0.0490
101 GAIT INABILITY 1636 0.0489
102 PULMONARY FIBROSIS 938 0.0488
103 FREQUENT BOWEL MOVEMENTS 1263 0.0467
104 MATERNAL EXPOSURE TIMING UNSPECIFIED 175 0.0465
105 RASH VESICULAR 225 0.0465
106 HEPATIC CIRRHOSIS 872 0.0464
107 OSTEOARTHRITIS 1924 0.0453
108 PRESCRIBED OVERDOSE 876 0.0452
109 ADVERSE REACTION 591 0.0445
110 FAECES SOFT 317 0.0435
111 DISCOMFORT 2594 0.0425
112 COELIAC DISEASE 416 0.0424
113 LIVER FUNCTION TEST INCREASED 908 0.0423
114 PRODUCT ADMINISTRATION INTERRUPTED 331 0.0421
115 BLISTER 2351 0.0418
116 BRONCHIAL WALL THICKENING 30 0.0417
117 INFUSION RELATED REACTION 2739 0.0413
118 HEPATIC ENZYME INCREASED 2737 0.0401
119 NIGHT SWEATS 1290 0.0400
120 PRODUCT SUPPLY ISSUE 285 0.0399
121 TASTE DISORDER 809 0.0398
122 BACTERIAL DISEASE CARRIER 29 0.0398
123 GASTRIC DISORDER 1366 0.0398
124 JOINT STIFFNESS 1036 0.0395
125 DIARRHOEA 25491 0.0395
126 INFLAMMATION 2008 0.0389
127 WHEEZING 2300 0.0387
128 ADVERSE DRUG REACTION 3414 0.0380
129 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 87 0.0377
130 MOBILITY DECREASED 2695 0.0375
131 UPPER RESPIRATORY TRACT INFECTION 1717 0.0371
132 KNEE ARTHROPLASTY 781 0.0371
133 BONE CYST 34 0.0362
134 LOWER RESPIRATORY TRACT INFECTION 1641 0.0360
135 PRESCRIBED UNDERDOSE 718 0.0360
136 INHIBITORY DRUG INTERACTION 56 0.0354
137 NORMAL NEWBORN 192 0.0353
138 GASTROINTESTINAL DISORDER 3125 0.0348
139 TONGUE DISORDER 251 0.0347
140 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2435 0.0342
141 STOMATITIS 2076 0.0342
142 TREATMENT FAILURE 2816 0.0340
143 MUSCULOSKELETAL STIFFNESS 2945 0.0336
144 DRUG INTOLERANCE 3187 0.0330
145 ROAD TRAFFIC ACCIDENT 1375 0.0328
146 SPINAL FUSION SURGERY 133 0.0328
147 ULCER HAEMORRHAGE 219 0.0323
148 JOINT DESTRUCTION 50 0.0321
149 SKIN NECROSIS 164 0.0316
150 EAR INFECTION 838 0.0315
151 INFECTION SUSCEPTIBILITY INCREASED 68 0.0310
152 SLEEP DISORDER 2172 0.0307
153 EYELID IRRITATION 77 0.0307
154 DRUG TOLERANCE 155 0.0306
155 RHEUMATOID ARTHRITIS 3462 0.0305
156 INJURY 2126 0.0302
157 LUNG DISORDER 1456 0.0297
158 HEADACHE 18572 0.0296
159 SWELLING 2762 0.0295
160 JOINT SWELLING 3519 0.0291
161 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 493 0.0290
162 NAUSEA 22866 0.0289
163 CONGENITAL ANOMALY 219 0.0283
164 DRUG-INDUCED LIVER INJURY 882 0.0281
165 CUTANEOUS T-CELL LYMPHOMA 35 0.0278
166 ILL-DEFINED DISORDER 1678 0.0276
167 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1318 0.0274
168 MIGRAINE 2614 0.0274
169 EPILEPSY 809 0.0264
170 GENERAL SYMPTOM 198 0.0264
171 DYSPEPSIA 2596 0.0264
172 MULTIPLE ALLERGIES 206 0.0263
173 GENERAL PHYSICAL HEALTH DETERIORATION 3015 0.0260
174 SINUSITIS 2659 0.0259
175 BRONCHIAL SECRETION RETENTION 33 0.0259
176 PREGNANCY 517 0.0258
177 DEPRESSION 5866 0.0258
178 DISABILITY 509 0.0257
179 MUSCULOSKELETAL PAIN 1342 0.0256
180 LIVER DISORDER 1133 0.0255
181 LICHEN PLANUS 59 0.0254
182 ABDOMINAL PAIN UPPER 5083 0.0247
183 MYOSITIS 219 0.0244
184 SINUS HEADACHE 143 0.0240
185 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 57 0.0240
186 OEDEMA 1301 0.0240
187 LATENT TUBERCULOSIS 50 0.0239
188 DELIRIUM 811 0.0233
189 BACK DISORDER 376 0.0231
190 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 394 0.0230
191 SEBORRHOEIC KERATOSIS 33 0.0227
192 DRY MOUTH 1818 0.0224
193 APPLICATION SITE INFLAMMATION 31 0.0224
194 MACULE 62 0.0223
195 SKIN PLAQUE 188 0.0223
196 THERAPEUTIC RESPONSE DECREASED 1346 0.0222
197 MATERNAL EXPOSURE DURING PREGNANCY 1957 0.0219
198 GRANULOMA 76 0.0219
199 INFECTION 3163 0.0218
200 EYE INJURY 66 0.0217
201 EAR PAIN 416 0.0214
202 OSTEOPOROSIS 880 0.0214
203 SENSITIVITY TO WEATHER CHANGE 112 0.0213
204 ARTHRITIS 1637 0.0208
205 GASTROOESOPHAGEAL REFLUX DISEASE 1672 0.0207
206 TENDONITIS 318 0.0205
207 RESPIRATORY DISORDER 600 0.0200
208 WEIGHT DECREASED 5588 0.0200
209 NASOPHARYNGITIS 3615 0.0196
210 PERIPHERAL SWELLING 2984 0.0193
211 HYPOAESTHESIA 2896 0.0193
212 SKIN INJURY 64 0.0193
213 APPLICATION SITE PARAESTHESIA 25 0.0192
214 BURNING SENSATION 1332 0.0190
215 SACROILIITIS 35 0.0185
216 INTENTIONAL PRODUCT USE ISSUE 1619 0.0185
217 DECREASED APPETITE 4279 0.0184
218 SKIN FISSURES 357 0.0182
219 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 953 0.0182
220 PRODUCT DOSE OMISSION ISSUE 5278 0.0179
221 FEAR OF INJECTION 128 0.0179
222 SKIN DISORDER 592 0.0177
223 BOWEL MOVEMENT IRREGULARITY 135 0.0176
224 HYPERSENSITIVITY 3272 0.0176
225 RASH 7683 0.0176
226 ALOPECIA 3449 0.0175
227 SKIN HAEMORRHAGE 260 0.0175
228 DEPRESSION SUICIDAL 60 0.0173
229 OSTEOLYSIS 35 0.0171
230 MEMORY IMPAIRMENT 2316 0.0168
231 NECK PAIN 936 0.0167
232 CONTUSION 1609 0.0167
233 ADVERSE EVENT 1516 0.0164
234 URTICARIA 2741 0.0163
235 HEPATIC FIBROSIS 56 0.0163
236 EXPOSURE DURING PREGNANCY 1014 0.0163
237 ARTHRALGIA 6770 0.0163
238 DANDRUFF 36 0.0163
239 HYPERTENSION 3428 0.0162
240 APPLICATION SITE SWELLING 80 0.0160
241 CONDITION AGGRAVATED 4879 0.0160
242 ESSENTIAL HYPERTENSION 29 0.0158
243 DRUG DOSE OMISSION 2619 0.0158
244 SPUTUM INCREASED 34 0.0157
245 MOOD ALTERED 426 0.0156
246 BASAL CELL CARCINOMA 243 0.0156
247 BRONCHITIS 1145 0.0155
248 SKIN ATROPHY 89 0.0154
249 THERAPY INTERRUPTED 1101 0.0154
250 ULCER 245 0.0154
251 SKIN DISCOMFORT 41 0.0152
252 JOINT ARTHROPLASTY 27 0.0151
253 HEPATITIS 385 0.0150
254 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 40 0.0150
255 SINUS PAIN 35 0.0150
256 HYPERCALCAEMIA 185 0.0150
257 ASTHMA 1693 0.0150
258 GLUCOSE TOLERANCE IMPAIRED 88 0.0149
259 DEPRESSIVE SYMPTOM 52 0.0147
260 RESPIRATORY TRACT INFECTION 382 0.0147
261 EPIGASTRIC DISCOMFORT 57 0.0146
262 VOMITING 6833 0.0145
263 POLYARTHRITIS 76 0.0144
264 INSOMNIA 3838 0.0144
265 AMNESIA 936 0.0144
266 DRUG EFFECT DECREASED 774 0.0144
267 PAPULE 101 0.0143
268 PARANASAL SINUS DISCOMFORT 54 0.0143
269 THERAPY PARTIAL RESPONDER 219 0.0140
270 VIRAL UPPER RESPIRATORY TRACT INFECTION 66 0.0139
271 DRUG INEFFECTIVE 18232 0.0138
272 PRURITUS 5296 0.0138
273 WEIGHT FLUCTUATION 144 0.0137
274 ECZEMA 720 0.0137
275 DEFAECATION URGENCY 96 0.0137
276 INFLAMMATORY BOWEL DISEASE 133 0.0136
277 GASTROENTERITIS VIRAL 243 0.0134
278 UNEVALUABLE EVENT 1005 0.0133
279 MUSCLE SPASMS 2418 0.0132
280 COLONOSCOPY 29 0.0132
281 CONFUSIONAL STATE 2113 0.0131
282 SPUTUM DISCOLOURED 124 0.0131
283 APPLICATION SITE BURN 64 0.0130
284 RASH PRURITIC 698 0.0129
285 PAIN 7772 0.0126
286 DRUG EFFECT LESS THAN EXPECTED 185 0.0125
287 PHARYNGITIS STREPTOCOCCAL 135 0.0125
288 UTERINE DISORDER 29 0.0124
289 SEASONAL ALLERGY 176 0.0124
290 SINUS DISORDER 246 0.0124
291 DRUG EFFECT INCOMPLETE 446 0.0123
292 MUSCULAR WEAKNESS 1376 0.0121
293 HYPERTRANSAMINASAEMIA 84 0.0121
294 DRUG ERUPTION 214 0.0121
295 FLATULENCE 683 0.0120
296 RESPIRATORY SYMPTOM 34 0.0119
297 DERMATITIS ATOPIC 630 0.0119
298 NO THERAPEUTIC RESPONSE 145 0.0119
299 MIDDLE EAR EFFUSION 26 0.0118
300 UPPER RESPIRATORY TRACT CONGESTION 34 0.0117
301 MUSCULOSKELETAL DISORDER 223 0.0117
302 MALAISE 5096 0.0116
303 EMPHYSEMA 117 0.0116
304 INFECTIOUS MONONUCLEOSIS 26 0.0116
305 IMMUNE SYSTEM DISORDER 150 0.0114
306 SKIN ULCER 289 0.0112
307 PRODUCT USE ISSUE 2098 0.0112
308 APPLICATION SITE URTICARIA 25 0.0111
309 PAIN IN EXTREMITY 3277 0.0111
310 WEIGHT INCREASED 2485 0.0111
311 SUSPECTED OFF LABEL USE 50 0.0111
312 SCAB 126 0.0110
313 PIGMENTATION DISORDER 68 0.0110
314 JOINT INJURY 235 0.0110
315 ABDOMINAL DISTENSION 1144 0.0109
316 INTENTIONAL PRODUCT MISUSE 955 0.0109
317 THERAPEUTIC PRODUCT EFFECT DELAYED 49 0.0107
318 SKIN HYPERTROPHY 30 0.0107
319 SCRATCH 112 0.0106
320 SQUAMOUS CELL CARCINOMA OF SKIN 64 0.0106
321 THERAPY CESSATION 544 0.0106
322 JOINT LOCK 30 0.0106
323 SHOULDER OPERATION 45 0.0105
324 AFFECTIVE DISORDER 82 0.0104
325 FULL BLOOD COUNT ABNORMAL 109 0.0103
326 EXFOLIATIVE RASH 27 0.0102
327 SKIN PAPILLOMA 41 0.0102
328 DERMATITIS 214 0.0102
329 SKIN LESION 280 0.0102
330 RESPIRATORY TRACT CONGESTION 162 0.0102
331 RHINORRHOEA 658 0.0102
332 ONYCHOCLASIS 70 0.0102
333 RASH MACULAR 353 0.0101
334 ROSACEA 47 0.0101
335 INFLUENZA 1124 0.0101
336 NASAL CONGESTION 592 0.0101
337 PNEUMONIA 3255 0.0100
338 GOUT 180 0.0100
339 SINUS CONGESTION 134 0.0099
340 SKIN EXFOLIATION 836 0.0099
341 NEGATIVE THOUGHTS 29 0.0099
342 FOOD POISONING 53 0.0099
343 FEELING JITTERY 187 0.0098
344 SPINAL CORD COMPRESSION 38 0.0097
345 GASTROINTESTINAL PAIN 107 0.0097
346 LOCALISED INFECTION 233 0.0096
347 ACTINIC KERATOSIS 25 0.0096
348 RED CELL DISTRIBUTION WIDTH INCREASED 40 0.0096
349 OBSTRUCTIVE AIRWAYS DISORDER 107 0.0096
350 APPLICATION SITE DISCOLOURATION 39 0.0096
351 EAR CONGESTION 26 0.0096
352 APPLICATION SITE ERYTHEMA 251 0.0096
353 GASTROINTESTINAL INFECTION 85 0.0095
354 CHEST PAIN 1756 0.0095
355 SPINAL OPERATION 116 0.0094
356 IMPAIRED QUALITY OF LIFE 135 0.0094
357 UPPER-AIRWAY COUGH SYNDROME 77 0.0093
358 SKIN EROSION 30 0.0093
359 DEPRESSED MOOD 492 0.0093
360 SPINAL DISORDER 88 0.0093
361 JOINT EFFUSION 64 0.0093
362 INFLAMMATORY MARKER INCREASED 46 0.0093
363 SKIN WEEPING 33 0.0092
364 MOOD SWINGS 294 0.0092
365 PARAESTHESIA 1451 0.0092
366 IMMUNOSUPPRESSION 81 0.0092
367 DIVERTICULITIS 254 0.0092
368 POLYMYALGIA RHEUMATICA 29 0.0091
369 POOR QUALITY SLEEP 196 0.0091
370 PRODUCT USE IN UNAPPROVED INDICATION 2255 0.0091
371 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 497 0.0090
372 LYME DISEASE 30 0.0090
373 IMMUNODEFICIENCY 134 0.0090
374 SKIN DISCOLOURATION 413 0.0090
375 PRODUCTIVE COUGH 429 0.0090
376 SUICIDAL IDEATION 801 0.0087
377 GALLBLADDER DISORDER 155 0.0087
378 FUNCTIONAL GASTROINTESTINAL DISORDER 30 0.0087
379 MELANOCYTIC NAEVUS 38 0.0087
380 FATIGUE 6744 0.0087
381 NEPHROLITHIASIS 397 0.0086
382 DECREASED INTEREST 51 0.0086
383 SKIN INFECTION 97 0.0086
384 BRONCHIECTASIS 58 0.0086
385 CELLULITIS 433 0.0086
386 ABDOMINAL PAIN 1998 0.0086
387 ORAL HERPES 167 0.0085
388 CONCUSSION 66 0.0085
389 BREATH SOUNDS ABNORMAL 42 0.0085
390 FOOT OPERATION 42 0.0085
391 MENISCUS INJURY 52 0.0084
392 TOOTH ABSCESS 86 0.0084
393 PAIN OF SKIN 226 0.0084
394 ANXIETY 2388 0.0084
395 SECRETION DISCHARGE 105 0.0084
396 OEDEMA PERIPHERAL 1021 0.0084
397 ARTHROPOD BITE 62 0.0084
398 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 245 0.0084
399 MUSCLE STRAIN 72 0.0083
400 INTENTIONAL DOSE OMISSION 236 0.0083
401 GASTROINTESTINAL SOUNDS ABNORMAL 41 0.0083
402 ARTHRITIS INFECTIVE 38 0.0082
403 WRIST FRACTURE 98 0.0082
404 SEBORRHOEA 30 0.0082
405 LABORATORY TEST ABNORMAL 239 0.0081
406 STREPTOCOCCAL INFECTION 45 0.0081
407 BACK PAIN 1871 0.0080
408 GAIT DISTURBANCE 1539 0.0080
409 PURPURA 71 0.0080
410 RETCHING 171 0.0080
411 RESPIRATION ABNORMAL 55 0.0080
412 INTRACRANIAL ANEURYSM 32 0.0080
413 TOOTH INFECTION 105 0.0080
414 DIZZINESS 3956 0.0079
415 VISUAL IMPAIRMENT 981 0.0079
416 FOOT FRACTURE 150 0.0079
417 BLOOD PRESSURE SYSTOLIC INCREASED 154 0.0079
418 SYMPTOM RECURRENCE 47 0.0078
419 INJECTION SITE REACTION 537 0.0078
420 ORAL DISORDER 57 0.0078
421 HERPES ZOSTER 445 0.0077
422 KNEE OPERATION 76 0.0077
423 DERMATITIS CONTACT 88 0.0077
424 RECTAL HAEMORRHAGE 331 0.0077
425 EAR DISCOMFORT 79 0.0077
426 B-CELL LYMPHOMA 26 0.0076
427 PULMONARY MASS 114 0.0076
428 SKIN BURNING SENSATION 548 0.0076
429 MALIGNANT MELANOMA 102 0.0076
430 OFF LABEL USE 6645 0.0076
431 GASTRIC INFECTION 29 0.0076
432 UPPER LIMB FRACTURE 151 0.0076
433 ARTHRITIS BACTERIAL 31 0.0075
434 NEURODERMATITIS 28 0.0075
435 MUSCLE SPASTICITY 92 0.0075
436 SKIN IRRITATION 343 0.0075
437 DERMATITIS EXFOLIATIVE GENERALISED 26 0.0075
438 FURUNCLE 59 0.0074
439 MEDICATION ERROR 411 0.0074
440 CHEILITIS 40 0.0074
441 ILLNESS 755 0.0073
442 NEOPLASM MALIGNANT 484 0.0072
443 COVID-19 1263 0.0072
444 SKIN CANCER 155 0.0072
445 SARS-COV-2 TEST POSITIVE 95 0.0072
446 SYNOVIAL CYST 33 0.0071
447 HEPATIC STEATOSIS 133 0.0071
448 WHITE BLOOD CELL COUNT INCREASED 273 0.0071
449 COUGH 1988 0.0071
450 PARANASAL SINUS HYPERSECRETION 27 0.0071
451 DYSPNOEA 3989 0.0070
452 PANCREATITIS 372 0.0070
453 RASH GENERALISED 182 0.0070
454 SPINAL PAIN 82 0.0070
455 SKIN ABRASION 33 0.0070
456 CARDIAC OPERATION 60 0.0070
457 REHABILITATION THERAPY 27 0.0070
458 SKIN REACTION 98 0.0069
459 HORDEOLUM 30 0.0069
460 ERUCTATION 134 0.0069
461 INTERVERTEBRAL DISC DEGENERATION 64 0.0069
462 FEELING HOT 424 0.0069
463 ASTHENIA 2588 0.0069
464 DRY SKIN 914 0.0068
465 TENDON PAIN 51 0.0067
466 KIDNEY INFECTION 132 0.0067
467 OVERWEIGHT 36 0.0067
468 APPLICATION SITE PRURITUS 152 0.0067
469 FUNGAL INFECTION 220 0.0066
470 LYMPHOMA 102 0.0066
471 TENDON DISORDER 43 0.0066
472 ANKLE FRACTURE 102 0.0066
473 VARICOSE VEIN 34 0.0066
474 CRYING 239 0.0066
475 PYREXIA 2272 0.0066
476 LIGAMENT RUPTURE 29 0.0066
477 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 47 0.0066
478 INCORRECT DOSAGE ADMINISTERED 32 0.0065
479 ERYTHEMA 1342 0.0065
480 LIMB INJURY 177 0.0065
481 GENERALISED ERYTHEMA 37 0.0065
482 APPETITE DISORDER 43 0.0065
483 HIP SURGERY 35 0.0065
484 EYE INFECTION 73 0.0065
485 OSTEOMYELITIS 117 0.0065
486 HYPERLIPIDAEMIA 77 0.0064
487 COLITIS ULCERATIVE 288 0.0064
488 PRODUCT COLOUR ISSUE 33 0.0064
489 SNEEZING 144 0.0064
490 MUSCULOSKELETAL DISCOMFORT 110 0.0064
491 FACIAL PAIN 57 0.0064
492 SQUAMOUS CELL CARCINOMA 60 0.0064
493 FAECES DISCOLOURED 138 0.0064
494 CORONAVIRUS INFECTION 42 0.0063
495 CONCOMITANT DISEASE AGGRAVATED 39 0.0063
496 RASH PUSTULAR 46 0.0063
497 TOOTH DISORDER 140 0.0063
498 URINE ODOUR ABNORMAL 37 0.0063
499 RHINITIS ALLERGIC 28 0.0063
500 FEEDING DISORDER 127 0.0063
501 LIMB OPERATION 30 0.0062
502 SKIN LACERATION 68 0.0062
503 ABNORMAL FAECES 51 0.0062
504 TACHYCARDIA 551 0.0062
505 FLUID RETENTION 314 0.0062
506 TENDERNESS 64 0.0061
507 UNDERDOSE 447 0.0061
508 EAR DISORDER 28 0.0061
509 QUALITY OF LIFE DECREASED 82 0.0061
510 POLYP 40 0.0061
511 SURGERY 358 0.0061
512 PAROSMIA 46 0.0061
513 CONJUNCTIVITIS 113 0.0061
514 ANKYLOSING SPONDYLITIS 80 0.0061
515 PULMONARY CONGESTION 80 0.0061
516 HEAD DISCOMFORT 107 0.0060
517 HERNIA 116 0.0060
518 BLOOD TEST ABNORMAL 84 0.0060
519 UVEITIS 81 0.0060
520 PRODUCT PHYSICAL CONSISTENCY ISSUE 33 0.0060
521 CYST 74 0.0060
522 SKIN HYPERPIGMENTATION 51 0.0059
523 ENERGY INCREASED 35 0.0059
524 ORAL CANDIDIASIS 78 0.0059
525 PRODUCT PRESCRIBING ERROR 141 0.0059
526 CYSTITIS 188 0.0059
527 SWELLING OF EYELID 37 0.0059
528 INSURANCE ISSUE 90 0.0059
529 INCREASED TENDENCY TO BRUISE 54 0.0059
530 ABNORMAL DREAMS 162 0.0059
531 INTERVERTEBRAL DISC PROTRUSION 128 0.0058
532 RALES 34 0.0058
533 NERVE COMPRESSION 54 0.0058
534 PRODUCT QUALITY ISSUE 793 0.0058
535 RASH ERYTHEMATOUS 279 0.0058
536 BREAST CANCER STAGE I 54 0.0058
537 PHOTOSENSITIVITY REACTION 96 0.0058
538 THERAPY CHANGE 57 0.0058
539 CARPAL TUNNEL SYNDROME 81 0.0058
540 THERMAL BURN 41 0.0058
541 SUNBURN 43 0.0058
542 THERAPEUTIC RESPONSE SHORTENED 191 0.0058
543 DECREASED IMMUNE RESPONSIVENESS 56 0.0057
544 COLITIS MICROSCOPIC 27 0.0057
545 FEELING ABNORMAL 1364 0.0057
546 MENSTRUAL DISORDER 47 0.0057
547 OROPHARYNGEAL PAIN 523 0.0056
548 INFLUENZA LIKE ILLNESS 465 0.0056
549 IRRITABILITY 337 0.0056
550 MASS 78 0.0056
551 IMPAIRED WORK ABILITY 119 0.0056
552 PEMPHIGOID 42 0.0056
553 SKIN MASS 37 0.0055
554 ADRENAL INSUFFICIENCY 67 0.0055
555 PANIC ATTACK 201 0.0055
556 DERMATITIS ALLERGIC 69 0.0055
557 DIARRHOEA HAEMORRHAGIC 51 0.0055
558 PALPITATIONS 638 0.0054
559 LIMB DISCOMFORT 168 0.0054
560 NEURALGIA 132 0.0054
561 MOUTH ULCERATION 114 0.0054
562 TREMOR 896 0.0054
563 RENAL PAIN 57 0.0054
564 INITIAL INSOMNIA 55 0.0054
565 NERVOUSNESS 280 0.0054
566 ASPARTATE AMINOTRANSFERASE INCREASED 284 0.0053
567 FRUSTRATION TOLERANCE DECREASED 43 0.0053
568 HEART RATE INCREASED 527 0.0053
569 SKIN SWELLING 46 0.0053
570 HYPERKERATOSIS 29 0.0053
571 CARDIAC VALVE DISEASE 30 0.0052
572 COLON CANCER 78 0.0052
573 DRY THROAT 53 0.0052
574 MAJOR DEPRESSION 38 0.0052
575 VIRAL INFECTION 173 0.0052
576 THYROID DISORDER 79 0.0051
577 SPINAL OSTEOARTHRITIS 45 0.0051
578 ACCIDENT 61 0.0051
579 URINARY TRACT INFECTION 868 0.0051
580 TOOTHACHE 92 0.0051
581 PRODUCT DISTRIBUTION ISSUE 47 0.0051
582 ANGER 171 0.0051
583 POLLAKIURIA 209 0.0050
584 SLUGGISHNESS 51 0.0050
585 COVID-19 PNEUMONIA 59 0.0050
586 RENAL DISORDER 232 0.0050
587 LIGAMENT SPRAIN 49 0.0050
588 HYPOACUSIS 213 0.0049
589 INCORRECT PRODUCT ADMINISTRATION DURATION 107 0.0049
590 DEAFNESS UNILATERAL 27 0.0049
591 MIDDLE INSOMNIA 91 0.0049
592 RASH PAPULAR 109 0.0049
593 MUSCULOSKELETAL CHEST PAIN 75 0.0048
594 HEART RATE ABNORMAL 27 0.0048
595 STENT PLACEMENT 39 0.0048
596 STAPHYLOCOCCAL INFECTION 159 0.0048
597 ALANINE AMINOTRANSFERASE INCREASED 295 0.0048
598 HOSPITALISATION 738 0.0048
599 BODY HEIGHT DECREASED 51 0.0048
600 PELVIC FRACTURE 37 0.0047
601 DISEASE RECURRENCE 226 0.0047
602 ROTATOR CUFF SYNDROME 61 0.0047
603 APPLICATION SITE IRRITATION 59 0.0047
604 NONSPECIFIC REACTION 26 0.0047
605 RHINITIS 38 0.0047
606 COLD SWEAT 83 0.0047
607 BRONCHOSPASM 67 0.0047
608 BRAIN NEOPLASM 43 0.0047
609 COMPRESSION FRACTURE 25 0.0047
610 BACTERIAL INFECTION 87 0.0047
611 BLOOD IRON DECREASED 55 0.0046
612 MYALGIA 788 0.0046
613 TENDON RUPTURE 57 0.0046
614 VITAMIN D DEFICIENCY 45 0.0046
615 SENSITIVE SKIN 34 0.0046
616 BLOOD PRESSURE INCREASED 699 0.0046
617 DIABETES MELLITUS 348 0.0046
618 POST PROCEDURAL INFECTION 37 0.0045
619 FALL 1512 0.0045
620 CARDIAC DISORDER 423 0.0045
621 NODULE 59 0.0045
622 HAND FRACTURE 32 0.0045
623 BIPOLAR DISORDER 49 0.0045
624 HIDRADENITIS 41 0.0045
625 CHEST DISCOMFORT 460 0.0045
626 APPLICATION SITE VESICLES 29 0.0045
627 CATARACT 266 0.0045
628 CHOLECYSTECTOMY 51 0.0045
629 HAEMATOCHEZIA 246 0.0045
630 PAIN IN JAW 126 0.0044
631 CANDIDA INFECTION 75 0.0044
632 FEELING OF BODY TEMPERATURE CHANGE 26 0.0044
633 LYMPHADENOPATHY 157 0.0044
634 NIGHTMARE 153 0.0044
635 ORAL PAIN 99 0.0044
636 NEPHROPATHY 41 0.0044
637 DRY EYE 219 0.0044
638 ASPIRATION 48 0.0044
639 PLEURISY 26 0.0044
640 TREATMENT NONCOMPLIANCE 239 0.0044
641 BODY TEMPERATURE INCREASED 89 0.0044
642 EYE SWELLING 162 0.0044
643 PRURITUS GENERALISED 94 0.0043
644 PSYCHIATRIC SYMPTOM 32 0.0043
645 EATING DISORDER 92 0.0043
646 HEPATITIS C 52 0.0043
647 HYSTERECTOMY 37 0.0043
648 POOR VENOUS ACCESS 44 0.0042
649 LEUKAEMIA 40 0.0042
650 EYE DISCHARGE 44 0.0042
651 BLADDER DISORDER 42 0.0042
652 APHONIA 59 0.0042
653 GASTRITIS 111 0.0042
654 GASTROINTESTINAL INFLAMMATION 33 0.0042
655 GASTRIC ULCER 80 0.0042
656 CARDIAC PACEMAKER INSERTION 25 0.0042
657 LYMPHOEDEMA 29 0.0042
658 BLOOD PRESSURE ABNORMAL 83 0.0042
659 FOOD ALLERGY 32 0.0041
660 SPINAL FRACTURE 83 0.0041
661 EYE DISORDER 136 0.0041
662 UTERINE CANCER 33 0.0041
663 FACIAL PARALYSIS 35 0.0041
664 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 737 0.0041
665 MYASTHENIA GRAVIS 33 0.0041
666 POOR QUALITY PRODUCT ADMINISTERED 43 0.0041
667 HAEMORRHOIDS 79 0.0040
668 PYELONEPHRITIS 35 0.0040
669 RIB FRACTURE 83 0.0040
670 CARDIAC FLUTTER 26 0.0040
671 HYPERAESTHESIA 33 0.0040
672 APHTHOUS ULCER 31 0.0040
673 VITAMIN D DECREASED 34 0.0040
674 THINKING ABNORMAL 74 0.0040
675 APPENDICITIS 37 0.0040
676 ABNORMAL LOSS OF WEIGHT 27 0.0040
677 PRODUCT DOSE OMISSION IN ERROR 112 0.0040
678 BONE DISORDER 72 0.0039
679 LUNG INFECTION 61 0.0039
680 PNEUMONIA BACTERIAL 36 0.0039
681 RESPIRATORY SYNCYTIAL VIRUS INFECTION 34 0.0039
682 DYSSTASIA 114 0.0039
683 TINNITUS 179 0.0039
684 EXPIRED PRODUCT ADMINISTERED 129 0.0039
685 THERAPEUTIC RESPONSE UNEXPECTED 174 0.0039
686 LOW DENSITY LIPOPROTEIN INCREASED 30 0.0039
687 HYPERSOMNIA 111 0.0039
688 POSTOPERATIVE WOUND INFECTION 26 0.0038
689 FLANK PAIN 36 0.0038
690 ATRIAL FIBRILLATION 374 0.0038
691 EYE PRURITUS 129 0.0038
692 MUSCLE DISORDER 31 0.0038
693 DYSPHONIA 222 0.0038
694 CEREBRAL DISORDER 28 0.0038
695 PNEUMOTHORAX 60 0.0038
696 TEMPERATURE INTOLERANCE 39 0.0038
697 PHOTOPHOBIA 71 0.0038
698 DYSPNOEA EXERTIONAL 142 0.0038
699 LETHARGY 216 0.0038
700 SWELLING FACE 244 0.0037
701 LUNG NEOPLASM MALIGNANT 154 0.0037
702 AUTOIMMUNE HEPATITIS 26 0.0037
703 EMOTIONAL DISORDER 115 0.0037
704 HAEMOPTYSIS 104 0.0037
705 LACERATION 35 0.0037
706 BLOOD URINE PRESENT 70 0.0037
707 NASAL DISCOMFORT 29 0.0037
708 MUSCLE TIGHTNESS 59 0.0036
709 ABDOMINAL PAIN LOWER 92 0.0036
710 APPLICATION SITE RASH 50 0.0036
711 MENTAL DISORDER 158 0.0036
712 RETINAL DETACHMENT 33 0.0036
713 MICTURITION URGENCY 41 0.0036
714 BONE PAIN 209 0.0036
715 SENSATION OF FOREIGN BODY 30 0.0036
716 SENSORY DISTURBANCE 57 0.0035
717 DYSURIA 130 0.0035
718 SLEEP APNOEA SYNDROME 67 0.0035
719 BREAST PAIN 37 0.0035
720 BREAST TENDERNESS 26 0.0034
721 VERTIGO 209 0.0034
722 OSTEOPENIA 52 0.0034
723 GROIN PAIN 30 0.0034
724 DYSGEUSIA 253 0.0034
725 HYPERHIDROSIS 436 0.0034
726 ACUTE RESPIRATORY FAILURE 65 0.0034
727 LACRIMATION INCREASED 101 0.0033
728 ANAL INCONTINENCE 30 0.0033
729 OROPHARYNGEAL DISCOMFORT 30 0.0033
730 THROAT IRRITATION 149 0.0033
731 CONSTIPATION 724 0.0033
732 ANGINA PECTORIS 95 0.0033
733 ARTERIAL OCCLUSIVE DISEASE 26 0.0033
734 PHARYNGITIS 41 0.0033
735 CLOSTRIDIUM DIFFICILE INFECTION 72 0.0033
736 DEHYDRATION 437 0.0033
737 OVARIAN CANCER 30 0.0033
738 IRON DEFICIENCY ANAEMIA 30 0.0032
739 NERVE INJURY 36 0.0032
740 HEART RATE IRREGULAR 73 0.0032
741 SENSORY LOSS 26 0.0032
742 APATHY 47 0.0032
743 OCULAR DISCOMFORT 36 0.0032
744 CLOSTRIDIUM DIFFICILE COLITIS 34 0.0032
745 RENAL IMPAIRMENT 269 0.0032
746 RESTLESS LEGS SYNDROME 58 0.0032
747 EYE IRRITATION 183 0.0032
748 ORAL DISCOMFORT 44 0.0032
749 HOT FLUSH 238 0.0032
750 BLOOD CREATININE INCREASED 205 0.0031
751 OCULAR HYPERAEMIA 149 0.0031
752 EOSINOPHIL COUNT INCREASED 26 0.0031
753 BEDRIDDEN 41 0.0031
754 PULMONARY THROMBOSIS 34 0.0031
755 GLAUCOMA 60 0.0031
756 CHILLS 364 0.0031
757 HYPOPHAGIA 79 0.0031
758 PRODUCT DISPENSING ERROR 67 0.0031
759 PHARYNGEAL SWELLING 30 0.0031
760 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 27 0.0031
761 HYPERTHYROIDISM 44 0.0030
762 THIRST 54 0.0030
763 INABILITY TO AFFORD MEDICATION 30 0.0030
764 AGEUSIA 75 0.0030
765 TRANSIENT ISCHAEMIC ATTACK 101 0.0030
766 HYPOAESTHESIA ORAL 45 0.0030
767 INTERNAL HAEMORRHAGE 34 0.0030
768 CARDIAC FAILURE CONGESTIVE 239 0.0030
769 INCORRECT DOSE ADMINISTERED 679 0.0030
770 ABSCESS 47 0.0029
771 MACULAR DEGENERATION 35 0.0029
772 HIP FRACTURE 94 0.0029
773 TOOTH FRACTURE 32 0.0029
774 MOVEMENT DISORDER 93 0.0029
775 LIP SWELLING 96 0.0029
776 INCREASED APPETITE 55 0.0029
777 ARTERIOSCLEROSIS 27 0.0029
778 HIATUS HERNIA 37 0.0029
779 DEATH 2452 0.0028
780 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 96 0.0028
781 CHROMATURIA 64 0.0028
782 VASCULITIS 33 0.0028
783 HAEMATEMESIS 71 0.0028
784 SALIVARY HYPERSECRETION 28 0.0028
785 COLITIS 106 0.0028
786 FRACTURE 52 0.0027
787 BRAIN FOG 43 0.0027
788 GASTROENTERITIS 40 0.0027
789 PHARYNGEAL OEDEMA 42 0.0027
790 OXYGEN SATURATION DECREASED 153 0.0027
791 SUPRAVENTRICULAR TACHYCARDIA 26 0.0027
792 BREAST CANCER 253 0.0027
793 BLOOD GLUCOSE ABNORMAL 50 0.0027
794 EPISTAXIS 202 0.0027
795 BLOOD POTASSIUM DECREASED 81 0.0027
796 ACNE 204 0.0027
797 MUSCLE ATROPHY 34 0.0027
798 HEPATOMEGALY 26 0.0026
799 PARAESTHESIA ORAL 38 0.0026
800 BLOOD PRESSURE DECREASED 175 0.0026
801 SCAR 45 0.0026
802 SWOLLEN TONGUE 82 0.0026
803 DEMENTIA 72 0.0026
804 THYROID CANCER 31 0.0026
805 IMPAIRED GASTRIC EMPTYING 35 0.0026
806 DEAFNESS 67 0.0026
807 BLOOD GLUCOSE FLUCTUATION 28 0.0026
808 EYE HAEMORRHAGE 34 0.0025
809 MENORRHAGIA 50 0.0025
810 MYOCARDIAL INFARCTION 444 0.0025
811 BODY TEMPERATURE DECREASED 25 0.0025
812 NEOPLASM 29 0.0025
813 CHOLELITHIASIS 82 0.0025
814 BLOOD PRESSURE FLUCTUATION 60 0.0025
815 FACE OEDEMA 42 0.0025
816 CEREBROVASCULAR ACCIDENT 421 0.0025
817 REBOUND EFFECT 28 0.0025
818 FOETAL EXPOSURE DURING PREGNANCY 201 0.0025
819 HEAD INJURY 77 0.0024
820 SEPSIS 271 0.0024
821 LEUKOPENIA 121 0.0024
822 EYE PAIN 136 0.0024
823 PNEUMONITIS 65 0.0024
824 BONE DENSITY DECREASED 73 0.0023
825 DISTURBANCE IN ATTENTION 125 0.0023
826 THROMBOSIS 186 0.0023
827 BLOOD TRIGLYCERIDES INCREASED 40 0.0023
828 GLYCOSYLATED HAEMOGLOBIN INCREASED 57 0.0023
829 SOMNOLENCE 452 0.0022
830 NEUROPATHY PERIPHERAL 213 0.0022
831 HAEMORRHAGE 230 0.0022
832 BACTERAEMIA 26 0.0022
833 BLOOD GLUCOSE DECREASED 105 0.0022
834 THROAT TIGHTNESS 59 0.0022
835 INTESTINAL OBSTRUCTION 82 0.0022
836 ANAPHYLACTIC SHOCK 56 0.0022
837 DYSPHAGIA 206 0.0022
838 TOOTH EXTRACTION 27 0.0022
839 HYPOTHYROIDISM 69 0.0022
840 RESTLESSNESS 79 0.0022
841 FEELING COLD 60 0.0022
842 PARANOIA 37 0.0021
843 ARRHYTHMIA 101 0.0021
844 ANGIOEDEMA 94 0.0021
845 INTRAOCULAR PRESSURE INCREASED 27 0.0021
846 GENERALISED OEDEMA 26 0.0021
847 PRODUCT USE COMPLAINT 33 0.0021
848 BLOOD POTASSIUM INCREASED 34 0.0021
849 CARDIAC FAILURE 167 0.0021
850 PRODUCT PRESCRIBING ISSUE 45 0.0021
851 BLINDNESS UNILATERAL 29 0.0021
852 RENAL FAILURE 273 0.0021
853 HEART RATE DECREASED 72 0.0020
854 POST PROCEDURAL COMPLICATION 39 0.0020
855 LOSS OF CONSCIOUSNESS 260 0.0020
856 AGITATION 149 0.0020
857 INFUSION SITE PAIN 26 0.0020
858 BLINDNESS 81 0.0020
859 VISION BLURRED 272 0.0020
860 PRESYNCOPE 48 0.0020
861 EXPOSURE VIA SKIN CONTACT 51 0.0020
862 PERIPHERAL COLDNESS 27 0.0020
863 FULL BLOOD COUNT DECREASED 39 0.0019
864 MULTIPLE SCLEROSIS 92 0.0019
865 CORONARY ARTERY OCCLUSION 26 0.0019
866 PRODUCT ADMINISTRATION ERROR 38 0.0019
867 EXTRA DOSE ADMINISTERED 76 0.0019
868 MUCOSAL INFLAMMATION 49 0.0019
869 HUNGER 26 0.0019
870 ACCIDENTAL OVERDOSE 68 0.0019
871 SEIZURE 214 0.0019
872 CHOKING 36 0.0018
873 BLOOD GLUCOSE INCREASED 345 0.0018
874 EOSINOPHILIA 32 0.0018
875 BLOOD SODIUM DECREASED 34 0.0018
876 ABORTION SPONTANEOUS 72 0.0018
877 HYPOKINESIA 26 0.0018
878 SYNCOPE 178 0.0018
879 PROSTATE CANCER 143 0.0018
880 OVERDOSE 383 0.0018
881 PRODUCT STORAGE ERROR 155 0.0018
882 THROMBOCYTOPENIA 198 0.0018
883 DISORIENTATION 70 0.0018
884 PSYCHOMOTOR HYPERACTIVITY 29 0.0017
885 GASTROINTESTINAL HAEMORRHAGE 146 0.0017
886 FEMUR FRACTURE 54 0.0017
887 RESPIRATORY FAILURE 127 0.0017
888 PRODUCT PHYSICAL ISSUE 35 0.0017
889 DIPLOPIA 45 0.0017
890 ANOSMIA 25 0.0017
891 DRUG PRESCRIBING ERROR 33 0.0017
892 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 122 0.0017
893 HALLUCINATION 129 0.0017
894 TRANSAMINASES INCREASED 38 0.0017
895 INJECTION SITE URTICARIA 41 0.0017
896 ACTIVITIES OF DAILY LIVING IMPAIRED 33 0.0017
897 BALANCE DISORDER 144 0.0017
898 PULMONARY OEDEMA 74 0.0017
899 BLOOD COUNT ABNORMAL 25 0.0016
900 MUSCLE TWITCHING 38 0.0016
901 RESPIRATORY DISTRESS 45 0.0016
902 SUICIDE ATTEMPT 96 0.0016
903 HYPOKALAEMIA 73 0.0016
904 ABASIA 39 0.0016
905 ANAPHYLACTIC REACTION 87 0.0016
906 DRUG ADMINISTRATION ERROR 48 0.0016
907 URINARY RETENTION 52 0.0016
908 CHRONIC KIDNEY DISEASE 118 0.0016
909 HAEMATURIA 52 0.0015
910 PROCEDURAL PAIN 42 0.0015
911 NERVOUS SYSTEM DISORDER 47 0.0015
912 MENSTRUATION IRREGULAR 40 0.0015
913 CORONARY ARTERY DISEASE 45 0.0015
914 HYPOXIA 52 0.0015
915 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 299 0.0015
916 SPEECH DISORDER 77 0.0015
917 INJECTION SITE RASH 45 0.0015
918 DEEP VEIN THROMBOSIS 95 0.0015
919 NO ADVERSE EVENT 264 0.0015
920 DEVICE MALFUNCTION 102 0.0015
921 LIVER FUNCTION TEST ABNORMAL 42 0.0014
922 INJECTION SITE PAIN 436 0.0014
923 ANAEMIA 270 0.0014
924 MENTAL IMPAIRMENT 34 0.0014
925 VAGINAL HAEMORRHAGE 60 0.0014
926 INJECTION SITE SWELLING 104 0.0014
927 HYPOTENSION 272 0.0014
928 INJECTION SITE BRUISING 107 0.0013
929 HEPATIC CANCER 32 0.0013
930 FLUSHING 134 0.0013
931 MELAENA 29 0.0013
932 INTERSTITIAL LUNG DISEASE 63 0.0013
933 INJECTION SITE MASS 48 0.0013
934 MENTAL STATUS CHANGES 36 0.0013
935 ACUTE MYOCARDIAL INFARCTION 38 0.0013
936 PANCREATIC CARCINOMA 37 0.0013
937 PRODUCT AVAILABILITY ISSUE 29 0.0013
938 BREAST CANCER FEMALE 34 0.0013
939 PERICARDIAL EFFUSION 29 0.0013
940 SEPTIC SHOCK 54 0.0012
941 CARDIOVASCULAR DISORDER 31 0.0012
942 PULMONARY EMBOLISM 116 0.0012
943 PSYCHOTIC DISORDER 36 0.0012
944 PALLOR 33 0.0012
945 PANCREATITIS ACUTE 27 0.0012
946 BLADDER CANCER 69 0.0012
947 ACCIDENTAL EXPOSURE TO PRODUCT 120 0.0012
948 HAEMOGLOBIN DECREASED 119 0.0012
949 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 54 0.0012
950 RED BLOOD CELL COUNT DECREASED 33 0.0012
951 INJECTION SITE PRURITUS 77 0.0011
952 URINARY INCONTINENCE 34 0.0011
953 CEREBRAL HAEMORRHAGE 41 0.0011
954 HYPOGLYCAEMIA 55 0.0011
955 DISEASE PROGRESSION 134 0.0011
956 ERECTILE DYSFUNCTION 29 0.0011
957 DRUG RESISTANCE 29 0.0011
958 WHITE BLOOD CELL COUNT DECREASED 120 0.0011
959 DRUG INTERACTION 175 0.0011
960 DEVICE ISSUE 96 0.0011
961 AGGRESSION 53 0.0011
962 PLEURAL EFFUSION 64 0.0011
963 HEPATIC FUNCTION ABNORMAL 39 0.0010
964 HAEMATOMA 27 0.0010
965 FEAR 28 0.0010
966 INCORRECT DOSE ADMINISTERED BY DEVICE 27 0.0010
967 HEPATIC FAILURE 31 0.0010
968 ABNORMAL BEHAVIOUR 40 0.0010
969 COGNITIVE DISORDER 47 0.0010
970 HYPERGLYCAEMIA 35 0.0010
971 EMOTIONAL DISTRESS 115 0.0009
972 INJECTION SITE ERYTHEMA 116 0.0009
973 WITHDRAWAL SYNDROME 39 0.0009
974 OESOPHAGEAL CARCINOMA 26 0.0009
975 INJECTION SITE HAEMORRHAGE 69 0.0009
976 APHASIA 26 0.0009
977 RENAL CANCER 37 0.0008
978 DYSARTHRIA 29 0.0008
979 COMA 34 0.0007
980 ACUTE KIDNEY INJURY 109 0.0007
981 PANCYTOPENIA 38 0.0007
982 CARDIAC ARREST 54 0.0007
983 PLATELET COUNT DECREASED 69 0.0006
984 MULTIPLE SCLEROSIS RELAPSE 43 0.0006
985 COMPLETED SUICIDE 43 0.0005
986 HYPONATRAEMIA 27 0.0005
987 TOXICITY TO VARIOUS AGENTS 47 0.0003
988 NEUTROPENIA 29 0.0002